Artiva Biotherapeutics (ARTV) Other Non Operating Income (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Other Non Operating Income data on file, last reported at $2000.0 in Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 150.0% year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was -$8000.0, a 99.17% increase from a year earlier, with the FY2025 full-year figure at -$14000.0, down 108.92% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $2000.0, up from -$2000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for ARTV reached as high as $1.1 million in Q4 2023 and fell as low as -$977000.0 in Q3 2024.
• Historically, Other Non Operating Income has averaged $28250.0 across 4 years, with a median of $0.0 in 2025.
• Across the five-year window, Other Non Operating Income tumbled 2054.0% in 2024 and soared 150.0% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at $1.1 million in 2023, then sank by 100.46% to -$5000.0 in 2024, then surged by 60.0% to -$2000.0 in 2025, then jumped by 200.0% to $2000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $2000.0 in Q1 2026, -$2000.0 in Q4 2025, and -$3000.0 in Q3 2025.